Choate Named 2021 “Patent Strategy Firm of the Year” by LMG Life Sciences

Choate is the 2021 LMG Life Sciences “Patent Strategy Firm of the Year,” announced yesterday evening at its annual awards ceremony in New York City. This is the second year in a decade that Choate has won this award, and Choate was selected over six other law firm finalists in the category this year.

Led by Dr. Brenda Herschbach Jarrell and Dr. Charles Lyon, Choate’s interdisciplinary Life Sciences practice is known for its combination of industry knowledge and legal and technical expertise. In its rankings, LMG Life Sciences describes Choate as “well known for its expertise in patent prosecution and strategy for life sciences clients, earning top ranking in these areas. The firm also has a significant practice focused on pharmaceutical patent litigation.”

Award winners are selected through a thorough research process that involves in-depth interviews with life sciences attorneys and professionals, detailed questionnaires provided by law firms, in-house client feedback, and an independent survey of industry developments and news.